Forte Biosciences (FBRX) Enterprise Value (QoQ) (2016 - 2026)
Forte Biosciences (FBRX) Enterprise Value (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Forte Biosciences | 1.36 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.37% |
| Dec 31, 2025 | 17.60% |
| Sep 30, 2025 | 11.97% |
| Jun 30, 2025 | -131.38% |
| Mar 31, 2025 | 21.43% |
| Dec 31, 2024 | -255.88% |
| Sep 30, 2024 | 33.06% |
| Jun 30, 2024 | 19.52% |
| Mar 31, 2024 | 18.00% |
| Dec 31, 2023 | 19.62% |
| Sep 30, 2023 | -51.80% |
| Jun 30, 2023 | 15.26% |
| Mar 31, 2023 | 12.65% |
| Dec 31, 2022 | 6.69% |
| Sep 30, 2022 | -14.41% |
| Jun 30, 2022 | 3.83% |
| Mar 31, 2022 | 4.78% |
| Dec 31, 2021 | 7.93% |
| Sep 30, 2021 | 10.11% |
| Jun 30, 2021 | 7.23% |